Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative GroupAnna Sureda, E. Condé, C. Ferrà et al.|Journal of Clinical Oncology|2001Cited by 233
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseAnna Sureda, E. Condé, M. Constans et al.|Annals of Oncology|2005Cited by 220
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?Jesús F. San Miguel, J Díaz-Mediavilla, Juan José Lahuerta et al.|The Hematology Journal|2000Cited by 117
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupMarı́a Dolores Caballero, E. Condé, Josè Antonio Pérez-Simón et al.|Annals of Oncology|2002Cited by 70